PSI CRO is a fully independent, privately owned Contract Research Organization (CRO) founded in 1995. The company specializes in managing pivotal Phase II and Phase III clinical trials across multiple therapeutic areas, including oncology and hematology. It operates in 58 countries with a team of over 3,200 professionals, and reports a 95% repeat and referral rate from its clients.
The company's technical focus includes clinical trial management, data-driven feasibility studies, and patient enrollment optimization. Its approach emphasizes predictable patient enrollment and personalized site support, using data to inform trial planning and execution. PSI CRO has received CRO Leadership Awards for seven consecutive years.
As a privately and organically grown organization, PSI CRO highlights a culture centered on partnership, trust, and international collaboration. The team operates with a people-first focus across its global network, working in diverse therapeutic areas within the clinical research industry.
